Blog

New CPIP Policy Brief: An Unwise Move to Discriminate Against Pharmaceutical Patents

CPIP has published a new policy brief entitled An Unwise Move to Discriminate Against Pharmaceutical Patents: Responding to the UN’s Guidelines for Pharmaceutical Patent Examination. The brief, written by CPIP Senior Scholar and UMKC Professor of Law Chris Holman, analyzes the UN’s recent Guidelines for Pharmaceutical Patent Examination, which are influential in the policy debates … Continue reading “New CPIP Policy Brief: An Unwise Move to Discriminate Against Pharmaceutical Patents”

Despite Professors’ Misleading Rhetoric, CLASSICS is a Big Win for Everyone

By Matthew Barblan America’s music industry is experiencing a historic moment. For the first time ever, stakeholders from across the industry have set aside their differences and come together to find a way to modernize our music licensing system. And what’s more, these diverse stakeholders—ranging from artists and record labels, to songwriters and music publishers, … Continue reading “Despite Professors’ Misleading Rhetoric, CLASSICS is a Big Win for Everyone”

CPIP Scholars Examine the Flaws in the Term “Evergreening”

In their new paper, Evergreening of Pharmaceutical Exclusivity: Sorting Fact from Misunderstanding and Fiction, Professors Kristina Acri née Lybecker and Mark Schultz, along with CPIP John F. Witherspoon Legal Fellow David Lund, analyze how the term “evergreening” is used in the context of pharmaceuticals. After sorting through the vagaries and rhetorical excesses that restrict meaningful … Continue reading “CPIP Scholars Examine the Flaws in the Term “Evergreening””

CPIP Scholars To Federal Circuit: Protect Innovation in the Life Sciences

Last week, a group of CPIP scholars—Chris Holman, David Lund, Adam Mossoff, and Kristen Osenga—filed an amicus brief in Natural Alternatives International v. Creative Compounds, a case currently on appeal to the U.S. Court of Appeals for the Federal Circuit. The amici ask the appellate court to correct the district court’s misapplication of the patent-eligibility … Continue reading “CPIP Scholars To Federal Circuit: Protect Innovation in the Life Sciences”

CPIP and ITIF Release Innovate4Health Report on Role of IP in Solving Global Health Challenges

This past Tuesday, CPIP and the Information Technology & Innovation Foundation (ITIF) released our joint report: Innovate4Health: How Innovators Are Solving Global Health Challenges. The report details 25 important healthcare innovations that are being created by and for people in the developing world, where some of the most urgent challenges remain. Each of these innovations is … Continue reading “CPIP and ITIF Release Innovate4Health Report on Role of IP in Solving Global Health Challenges”

Statement of Professor Adam Mossoff on Oil States v. Greene’s Energy

The statement below is from Professor Adam Mossoff, whose law review articles (here and here) were heavily cited in Justice Gorsuch’s dissent (joined by Chief Justice Roberts) in today’s opinion in Oil States v. Greene’s Energy. Adam Mossoff Professor of Law Antonin Scalia Law School, George Mason University For the first time, the Supreme Court … Continue reading “Statement of Professor Adam Mossoff on Oil States v. Greene’s Energy”

Department of Justice Recognizes Importance of Reliable Patent Rights in Innovation Economy

It is undeniable that the patent system has been under stress for the past decade, as courts, regulators, and even the Patent Office itself (as the newly confirmed Director Andrei Iancu has acknowledged) have sowed legal uncertainty, weakened patent rights, and even outright eliminated patent rights. This is why a series of recent speeches by … Continue reading “Department of Justice Recognizes Importance of Reliable Patent Rights in Innovation Economy”

CLASSICS Act Provides Long Overdue Recognition for Legacy Recording Artists

By Matthew Barblan & Kevin Madigan One of the oddities of US copyright law is that sound recordings—the way that our favorite songs are captured on media so that we can listen to them over and over again—were not protected under federal law until the early 1970s. Unfortunately, when the federal Copyright Act was finally … Continue reading “CLASSICS Act Provides Long Overdue Recognition for Legacy Recording Artists”

CASE Act Set to Empower Creators and Impose Accountability

Next week, the Copyright Alternative in Small Claims Enforcement (CASE) Act is scheduled for markup before the House Judiciary Committee, promising long-overdue support for small creators and copyright owners in their fight against overwhelming infringement in the digital age. While the bill has bipartisan support and the backing of a wide array of individual creators, … Continue reading “CASE Act Set to Empower Creators and Impose Accountability”

The STRONGER Patents Act: The House Receives Its Own Legislation to Protect Our Innovation Economy

Today, Representatives Steve Stivers (R-OH) and Bill Foster (D-IL) introduced the Support Technology & Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act of 2018. This important piece of legislation will protect our innovation economy by restoring stable and effective property rights for inventors. This legislation mirrors a bill already introduced in the … Continue reading “The STRONGER Patents Act: The House Receives Its Own Legislation to Protect Our Innovation Economy”